MedTrace Logo

Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation

NCT02068768 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2019-07-05

Study results available
· View outcomes & findings →

Summary

The purpose of this prospective clinical study is to examine the short-term safety and efficacy of the Avenue®- L interbody Spinal Fusion System with VerteBRIDGE® plating to treat one and two level degenerative disc disease between L2 and S1 with a focus on fusion rate.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

Avenue® L Interbody Fusion System (LDR Spine)

PEEK, intervertebral cage for interbody fusion of the lumbar spine

Sponsors & Collaborators

  • LDR Spine USA

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-15
Primary Completion
2016-03-09
Completion
2016-03-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02068768 on ClinicalTrials.gov